Monthly information related to total number of voting rights and shares composing the share capital - November 30, 2023
06 Dezembro 2023 - 6:05PM
Monthly information related to total number of voting rights and
shares composing the share capital - November 30, 2023
Monthly information related to total
number of voting rights and shares composing the share capital _
November 30, 2023
Article 223-16 of general regulation of
French Autorité des Marchés Financiers
Listing markets: Euronext Paris from Euronext
(Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)
& Nasdaq Global Select Market in the United-States (Symbol:
PHXM)Website : www.phaxiam.com
Date |
Total of shares composing the share capital |
Total of brut (1) voting
rights |
Total of net (2)
voting rights |
January 31, 2023 |
31 018 553 |
32 514 771 |
32 512 271 |
February 28, 2023 |
31 018 553 |
32 516 875 |
32 514 375 |
March 31, 2023 |
31 018 553 |
32 521 652 |
32 519 152 |
April 30, 2023 |
31 018 553 |
32 521 642 |
32 519 142 |
May 15, 2023 |
34 120 298 |
35 623 387 |
35 620 887 |
May 31, 2023 |
34 120 298 |
35 623 630 |
35 621 130 |
June 26, 2023 |
60 751 054 |
62 254 388 |
62 251 888 |
July 31, 2023 |
60 751 054 |
62 254 443 |
62 251 943 |
August 31, 2023 |
60 751 054 |
62 253 180 |
62 250 680 |
September 30, 2023 |
6 075 105 |
6 225 265 |
6 225 016 |
October 31, 2023 |
6 075 105 |
6 225 300 |
6 225 051 |
November 30, 2023 |
6 075 105 |
6 226 121 |
6 225 872 |
(1) Gross voting rights number
(or « theoretical » voting rights) is used as a basis for
calculating the crossing of the threshold. In accordance with
article 223-11 of general regulation of Autorité des Marchés
Financiers, this number is calculated on the basis of all shares
carrying the single and double voting rights, including shares
without voting rights.(2) Without treasury
shares.
- PR_Déclaration Droits de Vote_30112023_EN
PHAXIAM Therapeutics (EU:PHXM)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
PHAXIAM Therapeutics (EU:PHXM)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024